Evidence map›Paper›PMID 40231228›Full record

ArticleThe journal of allergy and clinical immunology. Global2025

Global productivity, international collaborations, and research trends in chronic spontaneous urticaria: A bibliometric overview.

Hugo W F Mak, Freya K L Chung, Philip H Li, Marcus Maurer

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hugo W F MakDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Freya K L ChungDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Philip H LiDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Marcus MaurerFraunhofer Institute for Translational Medicine and Pharmacology, Immunology and Allergology, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The treatment of chronic spontaneous urticaria (CSU) remains a challenge despite novel therapies such as omalizumab. With growing international interest in research on CSU, a comprehensive review of the global productivity, collaborations, and trending topics in CSU research may help inform future directions in patient management. Objectives: This study aims to outline the trends in CSU research by using bibliometric analysis, focusing specifically on global productivity, collaborative efforts, and emerging research topics spanning from 1977 to 2023. Methods: Publications related to CSU, including original articles, reviews, and letters, were sourced from the Web of Science Core Collection, and statistical analyses were performed using the Bibliometrix package in R and IBM SPSS Statistics. Results: A total of 2940 publications from 77 countries were analyzed. CSU research activity has increased exponentially since 2010, with more than half of the publications (50.2% [1477 of 2940]) published since 2016. These publications appeared in allergy, immunology, and dermatology journals led predominantly by European, Asian, and American researchers. International collaborations rose from 11.3% to 22.2%. Shifts in research focus, such as a shift in treatments from antihistamines to omalizumab, and growing emphasis on quality of life were noted. Conclusion: This study revealed a dynamic and increasingly collaborative CSU research landscape, emphasizing the need for continuous global partnerships to enhance treatment outcomes and improve patients' quality of life. Challenges regarding access to advanced therapies persist, highlighting the importance of expanding international collaborations and inclusive research practices.

Indexed as

Bibliometricchronicresearchspontaneoustrendsurticaria

Identifiers

PMID40231228
PMCPMC11994327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.